Related Experiment Video
Updated: May 7, 2026

09:25
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
19.1K
Surface proteomic analysis of differentiated versus stem-like osteosarcoma human cells
Marica Gemei1, Claudia Corbo, Francesca D'Alessio
1CEINGE-Biotecnologie Avanzate s.c.a.r.l, Napoli, Italy.
Proteomics
|October 10, 2013
Summary
This study identifies unique surface protein signatures for osteosarcoma cancer stem cells and differentiated cells. These findings advance understanding of cancer stem cell phenotypes and potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Cancer stem cells (CSCs) play a critical role in osteosarcoma (OS) initiation and progression.
- The specific surface phenotype of CSCs in OS remains largely uncharacterized.
- Understanding CSC surface markers is crucial for developing targeted therapies.
Purpose of the Study:
- To define the distinct surface protein profiles of stem-like and differentiated osteosarcoma cells.
- To identify potential biomarkers for osteosarcoma cancer stem cells.
Main Methods:
- Comparative cytometric analysis using an antibody-array of 245 membrane proteins.
- Utilized the stem-like 3-aminobenzamide-OS cell line and its parental differentiated MG63 cell line.
- Analysis of protein expression differences between the two cell models.
Main Results:
- Identified 50 differentially expressed, 23 homogeneously expressed, and 172 non-expressed proteins between the cell lines.
- Established unique surface protein signatures for stem-like and differentiated OS cells.
- Selected ERK1/2 (p44/42 mitogen-activated protein kinases) as a potentially correlated pathway with tumorigenic potential and stemness.
Conclusions:
- Distinct surface protein signatures differentiate stem-like from differentiated osteosarcoma cells.
- The identified signatures provide a basis for targeting CSCs in osteosarcoma.
- ERK1/2 pathway modulation may influence osteosarcoma stemness and tumorigenicity.

